"Xolair FDA Approval: Treating Severe Food Allergies"

The FDA has expanded the use of the asthma drug Xolair to help people with severe food allergies avoid serious reactions, making it the first medication approved for this purpose. Xolair, also known as omalizumab, can be taken by injection every two to four weeks and has been shown to help patients tolerate higher amounts of allergens. While it does not eliminate the need to avoid trigger foods, it provides a level of protection that could be life-changing for many allergy sufferers. However, the drug comes with potential side effects and a high cost, with the list price ranging from $2,900 to $5,000 per month.